Take your calendar out and save the days for these prostate cancer programs to inform and even entertain you
Must-see webinars
By Howard Wolinsky
Must-see webinars for Active Surveillors. (That means you.)
Marks this on your calendar: Drs. Mark Moyad and Mark Scholz’s prostate vaudeville act
The 2022 Moyad + Scholz Mid-Year Update is coming March 26-27.
One of the top features is Drs. Mark Scholz and Mark Moyad host an extended Q+A session about prostate cancer, where patients can get their questions answered.
It’s a popular act, right out of vaudeville or burlesque, with Moyad as the top banana and Scholz as the straight man. Or something like that. Very amusing and entertaining to see them hit the boards.
Don’t miss it live or on video.
Show some compassion
Likewise, don’t miss “Compassionate Care: Reducing Anxiety” webinar from Active Surveillance at 12 p.m. Eastern March 26.
ASPI is on a quest to find best practice in this area. What can we learn from the institutions that offer compassion? We also wish to learn from the woman who have journeyed through breast cancer.
Register here: https://aspatients.org/event/compassionate-care-reducing-anxiety/ If you are hanging out at PCRI, if you register you will get a link to this webinar.
Here’s the panel:
Dr. Madhavi Moharir will share her compassionate journey through breast cancer in Canada.
Robin Forbes, a Canadian social worker will share her role and experiences in giving compassionate care to cancer patients.
Andy Steinfeld will speak as an empowered patient.
Bill Manning, an ASPI leader and AS patient, will speak about Kaiser’s group support.
Fotini Elena Wolin, a Swedish senior oncology nurse, will share the Swedish approach.
March 24. 12-1:00 p.m. Cancer legal eagle.
Shelly Rosenfeld, Esq. Co-Director, Cancer Legal Resource Center Disability Rights Legal Center in Los Angeles, is holding a webinar covering legal issues that may stem from a cancer diagnosis, including employment law, insurance options and disability insurance, and laws that protect people affected by cancer. This “Empower Hour" webinar series is sponsored by a grant from the Tower Cancer Research Foundation. Register here: https://register.gotowebinar.com/register/5217105029338841869 Contact: SR@drlcenter.org Call 562.452.3182
Many men with low-risk to high-risk prostate cancer, including those on AS, experience “treatment regret” about their choice. Is it human nature to have buyer’s remorse? Learn more from Christopher Wallis, MD, PhD, of the University of Toronto, who has researched these second thoughts. He will answer general questions about prostate cancer.
Just drop in the Barniskis Room: https://www.gotomeet.me/AnswerCancer or call +1 646 749 3129 Access Code: 222-583-973 (Barniskis Room)
Support group meetings will be held the second through fourth Wednesdays at this location and time.
Don’t miss: World summit for Active Surveillors on the future of AS with leading prostate cancer MDs on April 22 at 11 a.m. Eastern.
Do you want to see where active surveillance is heading? Do you have some views you want to share?
Active Surveillance Patients International and the AnCan Virtual Support Group for Active Surveillance and other leading advocates and doctors are holding a free webinar, "Your Voice in the Future of Active Surveillance," on April 22 at 11 a.m.Eastern/4 p.m. GMT.
Sign up here ASAP: https://zoom.us/meeting/register/tJEtfuuqrzwtHNPuqzkigx65YBk8vV-teUdy
This webinar is a spinoff from two projects held this winter to address the future of AS.
Movember, the Australia-based men’s health organization, and Prostate Cancer International/University of Maryland held programs engaging patients and doctors on future directions for AS.
The leaders in this work, Dr. Minhaj Siddiqui, Professor, Urology, the University of Maryland, and Dr. Caroline Moore, Professor, Urology, University College London Division of Surgery and Interventional Medicine, representing Movember, will present their research to date at the webinar.
Panelists include:
--Dr. Peter Albertsen, a pioneer in active surveillance, is professor and chief of urology at the University of Connecticut.
--Dr. Chris Bangma, professor of urology at Erasmus Medical Center in Rotterdam, is a leader in the introduction of active surveillance in Europe. He is the coordinator of PRIAS and GAP3 studies.
--Dr. Ola Bratt, professor and consultant urological surgeon at the Prostate Cancer Centre, Sahlgrenska University Hospital Gothenburg, Sweden, and chairman of the National Prostate Cancer Guidelines Group in Sweden.
---Dr. E. David Crawford, professor of urology, University of California San Diego, and chairman, Prostate Conditions Education Council.
—Dr. Peter Carroll, professor, the UCSF Department of Urology, founded the Urologic Oncology Service at UCSF and is a pioneer in active surveillance.
—Dr. Laurence Klotz, professor and past chief, University of Toronto, Division of Urology, Sunnybrook Health Sciences Center, is another pioneer, who dubbed the strategy as "active surveillance.”
—Dr. Antonio Westphalen, faculty member, University of Washington Departments of Radiology, Urology, and Radiation Oncology, and chief of the Abdominal Imaging Section.
—Dr. Timothy Wilt is a health services researcher at the Minneapolis VA Center whose work led to the development of observation, watchful waiting, and screening of prostate cancer.
In addition to ASPI and AnCan, program sponsors include Europa UOMO, Prostate Cancer BC, Prostate Cancer Support Canada, the Prostate Forum of Orange County, the Walnut Foundation in Toronto, and TheActiveSurveillor.com newsletter (that’s me).
Please take TheActiveSurveillor.com survey on transperineal v. transrectal biopsies. Go to https://bit.ly/35mD6OY
Some interesting trends are emerging, such as the growing number of men who have opted for transperineal biopsies. Hope to see if the stats hold up with more data